{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:12:41Z","timestamp":1790723561250,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jaut.2024.103232","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T21:41:22Z","timestamp":1714513282000},"page":"103232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2377-5568","authenticated-orcid":false,"given":"Baozhen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yucong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinluan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.jaut.2024.103232_bib1","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jaut.2024.103232_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Bellutti Enders","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.jaut.2024.103232_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/jama.2010.1977","article-title":"Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies","volume":"305","author":"Rider","year":"2011","journal-title":"JAMA"},{"issue":"10019","key":"10.1016\/j.jaut.2024.103232_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(15)01021-1","article-title":"Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial","volume":"387","author":"Ruperto","year":"2016","journal-title":"Lancet Lond Engl"},{"issue":"2","key":"10.1016\/j.jaut.2024.103232_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.37754","article-title":"Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial","volume":"65","author":"Oddis","year":"2013","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jaut.2024.103232_bib6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/BOR.0000000000000538","article-title":"Juvenile dermatomyositis: novel treatment approaches and outcomes","volume":"30","author":"Varnier","year":"2018","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103232_bib7","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/rheumatology\/keac399","article-title":"Long-term follow-up of Janus-kinase inhibitor and novel active disease biomarker in juvenile dermatomyositis","volume":"62","author":"Huang","year":"2023","journal-title":"Rheumatol Oxf Engl"},{"issue":"5","key":"10.1016\/j.jaut.2024.103232_bib8","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/rheumatology\/keab601","article-title":"Siglec-1 expression on monocytes is associated with the interferon signature in juvenile dermatomyositis and can predict treatment response","volume":"61","author":"Lerkvaleekul","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.jaut.2024.103232_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/art.40800","article-title":"Muscle expression of type I and type II interferons is increased in juvenile dermatomyositis and related to clinical and histologic features","volume":"71","author":"Moneta","year":"2019","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.jaut.2024.103232_bib10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2567.2011.03412.x","article-title":"Regulation of effector and memory T-cell functions by type I interferon: type I interferon and adaptive T-cell functions","volume":"132","author":"Huber","year":"2011","journal-title":"Immunology"},{"issue":"5","key":"10.1016\/j.jaut.2024.103232_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1084\/jem.20050821","article-title":"Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection","volume":"202","author":"Kolumam","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.jaut.2024.103232_bib12","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.4049\/jimmunol.1103609","article-title":"Cutting edge: the role of IFN-\u03b1 receptor and MyD88 signaling in induction of IL-15 expression in vivo","volume":"188","author":"Colpitts","year":"2012","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib13","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.4049\/jimmunol.176.7.4284","article-title":"IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infections","volume":"176","author":"Bahl","year":"2006","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib14","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1002\/art.22654","article-title":"Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis","volume":"56","author":"Couzi","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/intimm\/dxv001","article-title":"Experimental myositis inducible with transfer of dendritic cells presenting a skeletal muscle C protein-derived CD8 epitope peptide","volume":"27","author":"Okiyama","year":"2015","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.jaut.2024.103232_bib16","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/annrheumdis-2020-218661","article-title":"Immune response to dermatomyositis-specific autoantigen, transcriptional intermediary factor 1\u03b3 can result in experimental myositis","volume":"80","author":"Okiyama","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2024.103232_bib17","article-title":"Single-cell profiling of peripheral blood and muscle cells reveals inflammatory features of juvenile dermatomyositis","volume":"11","author":"Chen","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.jaut.2024.103232_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis: (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.jaut.2024.103232_bib20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/annrheumdis-2020-218582","article-title":"Janus kinase inhibitor significantly improved rash and muscle strength in juvenile dermatomyositis","volume":"80","author":"Ding","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.jaut.2024.103232_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2353\/ajpath.2009.080422","article-title":"Role of regulatory T cells in a new mouse model of experimental autoimmune myositis","volume":"174","author":"Allenbach","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103232_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2121-9-13","article-title":"Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissue","volume":"9","author":"Robertson","year":"2008","journal-title":"BMC Cell Biol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103232_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13075-020-02161-8","article-title":"Higher interferon score and normal complement levels may identify a distinct clinical subset in children with systemic lupus erythematosus","volume":"22","author":"Tesser","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"2","key":"10.1016\/j.jaut.2024.103232_bib24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/art.41078","article-title":"Neutrophil extracellular traps in tissue and periphery in juvenile dermatomyositis","volume":"72","author":"Duvvuri","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103232_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.134189","article-title":"Neutrophil dysregulation is pathogenic in idiopathic inflammatory myopathies","volume":"5","author":"Seto","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib26","doi-asserted-by":"crossref","first-page":"e739","DOI":"10.1212\/WNL.0000000000013176","article-title":"Dermatomyositis: muscle pathology according to antibody subtypes","volume":"98","author":"Tanboon","year":"2022","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.jaut.2024.103232_bib27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1600-0560.2007.00848.x","article-title":"Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus","volume":"35","author":"McNiff","year":"2008","journal-title":"J. Cutan. Pathol."},{"issue":"4","key":"10.1016\/j.jaut.2024.103232_bib28","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1093\/brain\/awl020","article-title":"Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis","volume":"129","author":"Dimitri","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2024.103232_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.902232","article-title":"Multi-modal single-cell sequencing identifies cellular immunophenotypes associated with juvenile dermatomyositis disease activity","volume":"13","author":"Neely","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103232_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12967-020-02290-3","article-title":"TLR expression in peripheral monocyte subsets of patients with idiopathic inflammatory myopathies: association with clinical and immunological features","volume":"18","author":"Torres-Ruiz","year":"2020","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.jaut.2024.103232_bib31","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1354\/vp.39-4-512","article-title":"Myofiber expression of class I major histocompatibility complex accompanied by CD8+ T-cell-associated myofiber injury in a case of canine polymyositis","volume":"39","author":"Morita","year":"2002","journal-title":"Vet. Pathol."},{"issue":"16","key":"10.1016\/j.jaut.2024.103232_bib32","doi-asserted-by":"crossref","first-page":"9209","DOI":"10.1073\/pnas.97.16.9209","article-title":"Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies","volume":"97","author":"Nagaraju","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jaut.2024.103232_bib33","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2353\/ajpath.2009.090196","article-title":"Overexpression of MHC class I heavy chain protein in young skeletal muscle leads to severe myositis","volume":"175","author":"Li","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2024.103232_bib34","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3389\/fimmu.2018.02692","article-title":"Defining memory CD8 T cell","volume":"9","author":"Martin","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103232_bib35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2249.2004.02500.x","article-title":"Oligoclonal expansion of circulating and tissue-infiltrating CD8+ T Cells with killer\/effector phenotypes in juvenile dermatomyositis syndrome","volume":"137","author":"Mizuno","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.jaut.2024.103232_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13075-020-02160-9","article-title":"Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies","volume":"22","author":"Kim","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.jaut.2024.103232_bib37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/BOR.0000000000000816","article-title":"Updates on interferon in juvenile dermatomyositis: pathogenesis and therapy","volume":"33","author":"Kim","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jaut.2024.103232_bib38","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fimmu.2016.00498","article-title":"Viral evasion strategies in type I IFN signaling - a summary of recent developments","volume":"7","author":"Schulz","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.jaut.2024.103232_bib39","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ni1213","article-title":"A critical function for type I interferons in cancer immunoediting","volume":"6","author":"Dunn","year":"2005","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.jaut.2024.103232_bib40","first-page":"187","article-title":"Pathophysiology and pharmacology of systemic lupus erythematosus","volume":"44","author":"Schneider","year":"1993","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc."},{"issue":"2","key":"10.1016\/j.jaut.2024.103232_bib41","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2567.2001.01193.x","article-title":"Specificity, restriction and effector mechanisms of immunoregulatory CD8 T cells","volume":"102","author":"Vukmanovic\u2010Stejic","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.jaut.2024.103232_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3389\/fimmu.2017.01215","article-title":"Coinhibitory receptor expression and immune checkpoint blockade: maintaining a balance in CD8+ T cell responses to chronic viral infections and cancer","volume":"8","author":"Okoye","year":"2017","journal-title":"Front. Immunol."},{"issue":"1_Supplement","key":"10.1016\/j.jaut.2024.103232_bib43","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.204.Supp.155.16","article-title":"CD8 T cell fate is programmed by a miRNA-mediated mechanism","volume":"204","author":"Pobezinsky","year":"2020","journal-title":"J. Immunol."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841124000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T23:57:08Z","timestamp":1717631828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841124000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"alternative-id":["S0896841124000660"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103232","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated type I IFN signalling directly affects CD8+ T-cell distribution and autoantigen recognition of the skeletal muscles in active JDM patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2024.103232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103232"}}